Radiotherapy of the Primary Disease for Synchronous Metastatic Cancer: A Systematic Review.
locoregional treatment
metastatic cancer
oligometastatic cancer
primary tumor
radiotherapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
30 Nov 2022
30 Nov 2022
Historique:
received:
22
10
2022
revised:
24
11
2022
accepted:
26
11
2022
entrez:
11
12
2022
pubmed:
12
12
2022
medline:
12
12
2022
Statut:
epublish
Résumé
In the case of synchronous metastatic disease, the local treatment of primary tumors by radiotherapy has long been reserved for palliative indications. The emergence of the concept of oligometastatic and oligopersistent diseases, the advent of new systemic therapies enabling longer overall survival with an enhanced quality of life, a better understanding of the biologic history of metastatic spread, and technical advances in radiation therapy are revolutionizing the management of patients with de novo metastatic cancer. The prognosis of these patients has been markedly improved and many studies have investigated the survival benefits from the local treatment of various primary tumors in cases of advanced disease at the time of diagnosis or in the case of oligopersistence. This article provides an update on the place of irradiation of the primary tumor in cancer with synchronous metastases, and discusses its interest through published or ongoing trials.
Identifiants
pubmed: 36497410
pii: cancers14235929
doi: 10.3390/cancers14235929
pmc: PMC9736289
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Ann Oncol. 2018 Jan 1;29(suppl_1):i20-i27
pubmed: 29462255
N Engl J Med. 2018 Nov 22;379(21):2027-2039
pubmed: 30280657
N Engl J Med. 2018 May 31;378(22):2078-2092
pubmed: 29658856
Lancet Oncol. 2016 Dec;17(12):1672-1682
pubmed: 27789196
Lung Cancer. 2019 Apr;130:67-75
pubmed: 30885354
N Engl J Med. 2020 Nov 19;383(21):2018-2029
pubmed: 33207094
Lung Cancer. 2015 Dec;90(3):477-83
pubmed: 26604031
Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):880-7
pubmed: 24867533
Ann Surg Oncol. 2007 Dec;14(12):3345-51
pubmed: 17687611
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):39-45
pubmed: 22330986
Cancer. 2020 Nov 15;126(22):4867-4877
pubmed: 32914866
Cancer Radiother. 2019 Jul;23(4):346-354
pubmed: 31130373
Surgery. 2002 Oct;132(4):620-6; discussion 626-7
pubmed: 12407345
Lung Cancer. 2020 Apr;142:41-46
pubmed: 32088604
Nat Rev Immunol. 2002 Aug;2(8):569-79
pubmed: 12154376
Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):774-80
pubmed: 25752391
PLoS One. 2016 Jan 25;11(1):e0147191
pubmed: 26807740
Int J Cancer. 2017 Jun 15;140(12):2805-2819
pubmed: 28295308
Cancer Sci. 2020 Dec;111(12):4442-4452
pubmed: 32770608
BMC Cancer. 2021 Apr 30;21(1):482
pubmed: 33931014
J Thorac Oncol. 2012 Oct;7(10):1547-55
pubmed: 22982655
Int J Cancer. 2021 Nov 15;149(10):1828-1832
pubmed: 34270809
Eur J Surg Oncol. 2009 Nov;35(11):1146-51
pubmed: 19398188
J Nucl Med. 2021 May 14;:
pubmed: 33990403
J Natl Compr Canc Netw. 2021 Mar 02;19(3):254-266
pubmed: 33668021
Lancet. 2016 Apr 9;387(10027):1540-1550
pubmed: 26712084
Transl Lung Cancer Res. 2020 Dec;9(6):2479-2493
pubmed: 33489808
JAMA Surg. 2016 May 1;151(5):424-31
pubmed: 26629881
Cancer. 2008 Oct 15;113(8):2011-9
pubmed: 18780312
Lancet. 2022 Apr 30;399(10336):1695-1707
pubmed: 35405085
Eur Urol. 2017 Jul;72(1):14-19
pubmed: 27174537
Br J Radiol. 2018 May;91(1085):20170822
pubmed: 29350548
BMB Rep. 2016 Jan;49(1):18-25
pubmed: 26592936
Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):527-535
pubmed: 30003996
J Thorac Oncol. 2015 Nov;10(11):1601-7
pubmed: 26313684
Cancer. 2010 Mar 1;116(5):1226-33
pubmed: 20101736
Prostate. 2017 May;77(6):559-572
pubmed: 28093791
Breast Cancer Res Treat. 2009 May;115(1):7-12
pubmed: 18581232
Cancer Metastasis Rev. 2006 Dec;25(4):521-9
pubmed: 17186383
Int J Cancer. 2019 May 15;144(10):2605-2612
pubmed: 30387880
Cancer Genomics Proteomics. 2017 01-02;14(1):1-15
pubmed: 28031234
Eur Urol. 2017 Jul;72(1):118-124
pubmed: 28385454
Lancet. 2015 Jan 3;385(9962):36-42
pubmed: 25230595
BMJ Open. 2018 Apr 17;8(4):e020690
pubmed: 29666135
Adv Anat Pathol. 2019 Jan;26(1):69-74
pubmed: 30339548
Radiother Oncol. 2020 Apr;145:109-116
pubmed: 31931289
Ann Surg Oncol. 2008 Dec;15(12):3384-95
pubmed: 18726129
Eur Urol. 2021 Feb;79(2):188-197
pubmed: 32978014
Eur Urol. 2014 Jun;65(6):1058-66
pubmed: 24290503
Cell. 2009 Dec 24;139(7):1315-26
pubmed: 20064377
J Clin Oncol. 2006 Jun 20;24(18):2743-9
pubmed: 16702580
Cancer Metastasis Rev. 1989 Aug;8(2):98-101
pubmed: 2673568
Sci Rep. 2020 Feb 19;10(1):2952
pubmed: 32076063
Clin Cancer Res. 2012 Mar 1;18(5):1472-82
pubmed: 22235099
Ann Surg Oncol. 2006 Jun;13(6):776-82
pubmed: 16614878
JAMA Oncol. 2019 Sep 01;5(9):1283-1290
pubmed: 31294762
Eur Urol. 2015 Jan;67(1):3-6
pubmed: 25217422
Crit Rev Oncol Hematol. 2013 Jul;87(1):69-79
pubmed: 23369750
N Engl J Med. 2015 Oct 22;373(17):1627-39
pubmed: 26412456
J Thorac Dis. 2017 Feb;9(2):310-317
pubmed: 28275479
Ann Surg Oncol. 2018 Oct;25(11):3141-3149
pubmed: 29777404
Ann Oncol. 2015 Sep;26(9):1883-1889
pubmed: 26105600
Cancer Radiother. 2017 May;21(3):244-255
pubmed: 28522277
Ann Oncol. 2014 Oct;25(10):1954-1959
pubmed: 25114022
Ann Surg Oncol. 2013 Jun;20(6):1893-9
pubmed: 23306905
J Urol. 2015 Aug;194(2):378-85
pubmed: 25711194
Int J Radiat Oncol Biol Phys. 2022 Dec 1;114(5):919-935
pubmed: 35840112
Eur Urol. 2019 Jul;76(1):115-124
pubmed: 30826218
J Clin Oncol. 2009 Mar 20;27(9):1375-81
pubmed: 19204198
Clin Breast Cancer. 2018 Apr;18(2):e167-e178
pubmed: 28689012
Ann Surg. 2008 May;247(5):732-8
pubmed: 18438108
J Clin Oncol. 2016 Aug 20;34(24):2835-42
pubmed: 27325855
Int J Radiat Oncol Biol Phys. 2022 Nov 15;114(4):611-616
pubmed: 35643253
Transl Lung Cancer Res. 2019 Nov;8(Suppl 3):S247-S264
pubmed: 31857949
Nat Rev Clin Oncol. 2011 Jun;8(6):369-77
pubmed: 21522121
Jpn J Clin Oncol. 2012 Oct;42(10):970-3
pubmed: 22833684
J Clin Oncol. 2022 Mar 20;40(9):978-987
pubmed: 34995128
Lancet. 2018 Dec 1;392(10162):2353-2366
pubmed: 30355464
Eur Urol. 2019 Mar;75(3):410-418
pubmed: 30266309
Breast Cancer Res Treat. 2018 Jun;169(2):287-293
pubmed: 29374851
Am J Clin Oncol. 2020 Dec 1;43(12):895-901
pubmed: 33027084
Cancer Radiother. 2021 Oct;25(6-7):517-522
pubmed: 34175225
Eur Urol. 2021 Feb;79(2):243-262
pubmed: 33172724
Radiother Oncol. 2010 Aug;96(2):199-203
pubmed: 20347167
JAMA Oncol. 2018 Jan 11;4(1):e173501
pubmed: 28973074
Cancer Res. 2006 Dec 1;66(23):11089-93
pubmed: 17145848
J Thorac Oncol. 2018 Sep;13(9):1383-1392
pubmed: 29852232
Int J Mol Sci. 2017 Mar 02;18(3):
pubmed: 28257101
Ann Surg Oncol. 2007 Aug;14(8):2187-94
pubmed: 17522944
Ann Surg Oncol. 2021 May;28(5):2646-2658
pubmed: 33128117
Lancet Oncol. 2015 Oct;16(13):1380-8
pubmed: 26363985
J Cancer Res Clin Oncol. 2017 Sep;143(9):1701-1712
pubmed: 28429102
Eur J Surg Oncol. 2018 Oct;44(10):1504-1512
pubmed: 30146252
Am J Clin Oncol. 2000 Feb;23(1):89-93
pubmed: 10683087
J Thorac Oncol. 2016 Jan;11(1):39-51
pubmed: 26762738
Br J Cancer. 2020 Sep;123(6):905-908
pubmed: 32595213
J Thorac Oncol. 2013 Mar;8(3):346-51
pubmed: 23407558
J Natl Cancer Inst. 2022 Jan 30;:
pubmed: 35094066
Oncologist. 2016 Aug;21(8):964-73
pubmed: 27354669
Cancer Radiother. 2022 Feb-Apr;26(1-2):329-343
pubmed: 34955419
Breast. 2016 Aug;28:73-8
pubmed: 27240169
JAMA Oncol. 2021 Apr 01;7(4):555-563
pubmed: 33599706
Lung Cancer. 2018 Dec;126:194-200
pubmed: 30527187
Radiol Med. 2019 Jul;124(7):662-670
pubmed: 30771218
Ann Surg. 2019 Jun;269(6):1163-1169
pubmed: 31082916
J Clin Oncol. 2019 Jun 20;37(18):1558-1565
pubmed: 31067138
J Clin Oncol. 2020 Sep 1;38(25):2830-2838
pubmed: 32484754
Oncol Rep. 2009 Mar;21(3):827-32
pubmed: 19212646
Lancet Oncol. 2020 Jan;21(1):e18-e28
pubmed: 31908301